If You Invested in Berto Acquisition Corp (TACO)

Berto Acquisition Corp. (NASDAQ: TACO) is a special purpose acquisition company (SPAC) whose ordinary shares trade on The Nasdaq Stock Market LLC under the symbol TACO. According to its public filings, the company is organized in the Cayman Islands and has securities listed on Nasdaq, including ordinary shares, units, and warrants. As a blank check company, Berto Acquisition Corp. was formed to pursue a business combination, as reflected in its description as a blank check company and its subsequent disclosure activity.

The company’s capital structure, as disclosed in its Form 8-K, includes: (i) units consisting of one ordinary share and one-half of one redeemable warrant trading under the symbol TACOU, (ii) ordinary shares trading under the symbol TACO, and (iii) warrants entitling the holder to purchase one ordinary share trading under the symbol TACOW. These securities are registered under Section 12(b) of the Securities Exchange Act of 1934 and listed on The Nasdaq Stock Market LLC.

Business purpose as a SPAC

Berto Acquisition Corp. is identified in its SEC filings as a special purpose acquisition company. SPACs generally raise capital in public markets to seek and complete a business combination with one or more operating businesses, and Berto’s activities described in its filings are consistent with that structure. The company’s Form 8-K dated October 29, 2025, describes its efforts to pursue a potential business combination with an operating company in the healthcare infrastructure space.

Letter of intent with OnMed LLC

On October 29, 2025, Berto Acquisition Corp. and OnMed LLC jointly announced that they had entered into a non-binding letter of intent for a potential business combination. The Form 8-K filed by Berto states that OnMed is a developer of healthcare infrastructure solutions and that the parties signed a non-binding letter of intent for a potential business combination. The filing emphasizes that there can be no assurances that Berto and OnMed will successfully negotiate and enter into a definitive agreement or that any proposed transaction will be consummated. Any transaction would be subject to due diligence, negotiation of a definitive agreement, board and equity holder approvals, regulatory approvals, and other customary conditions.

The joint press release referenced in Berto’s Form 8-K describes OnMed as the creator of the OnMed CareStation, which is characterized as a healthcare access infrastructure solution. The release explains that the OnMed CareStation is designed to address healthcare access challenges through a clinic-in-a-box concept and that OnMed positions its CareStations as addressing clinical shortcomings of telemedicine and scalability challenges of traditional in-office clinics. The press release also notes that the combined company is expected to be publicly listed if a definitive agreement is executed and the transaction is completed, though this expectation is explicitly subject to the same conditions and uncertainties described in the Form 8-K.

Regulatory reporting and investor communications

Berto Acquisition Corp. uses SEC filings, including Form 8-K, to report material events such as the execution of a non-binding letter of intent. In its October 29, 2025 Form 8-K, Berto indicates that if a definitive agreement is entered into in connection with the proposed business combination, Berto or a newly formed holding company will prepare a registration statement, including a proxy statement/prospectus, to be filed with the U.S. Securities and Exchange Commission. The filing explains that the proxy statement/prospectus would be mailed to Berto’s shareholders and would contain important information about the proposed business combination.

The Form 8-K also notes that investors and other interested persons can review Berto’s reports filed with the SEC to obtain information about the security holdings of its officers and directors and their respective interests as security holders in the consummation of transactions described in those filings. These reports, along with any future proxy statement/prospectus related to a business combination, are available through the SEC’s EDGAR system.

Forward-looking statements and transaction conditions

The Form 8-K and the related press release include cautionary language about forward-looking statements. They explain that expectations, estimates, and projections regarding the businesses of Berto and OnMed may differ from actual results and that words such as “expect,” “estimate,” “project,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” and “continue” are intended to identify such forward-looking statements. The documents highlight that forward-looking statements include expectations regarding future performance, anticipated financial impacts of any proposed transaction, satisfaction of closing conditions, and timing of completion, and that these statements are subject to risks and uncertainties.

The Form 8-K further clarifies that the filing and its exhibit do not constitute an offer to sell or the solicitation of an offer to buy any securities, nor a solicitation of any proxy, consent, or authorization with respect to any securities or the proposed transaction. Any offer or sale of securities would need to comply with applicable registration or qualification requirements under securities laws.

Status and sector classification

Based on the available information, Berto Acquisition Corp. is a publicly traded SPAC with ordinary shares, units, and warrants listed on Nasdaq. The company is organized in the Cayman Islands and maintains principal executive offices in Las Vegas, Nevada, as disclosed in its Form 8-K. Sector and industry classifications may describe it as a blank check company, and the Polygon description also identifies Berto Acquisition Corp. as a blank check company. Its activities are centered on identifying and potentially combining with an operating business, as reflected in its non-binding letter of intent with OnMed LLC.

Key characteristics

• Entity type: Special purpose acquisition company (blank check company), as described in SEC filings and third-party classification.
• Jurisdiction of organization: Cayman Islands, according to the Form 8-K.
• Listing venue: The Nasdaq Stock Market LLC, with symbols TACO (ordinary shares), TACOU (units), and TACOW (warrants), as disclosed in the Form 8-K.
• Disclosed transaction activity: Non-binding letter of intent with OnMed LLC for a potential business combination, subject to negotiation and approvals, as reported in the Form 8-K and joint press release.

Investor considerations based on available disclosures

According to its Form 8-K, Berto Acquisition Corp. intends that, if a definitive agreement is reached for a business combination, a registration statement containing a proxy statement/prospectus would be filed with the SEC. The company urges investors and other interested persons to read that proxy statement/prospectus, when available, as well as other documents filed with the SEC, because they will contain important information about any proposed business combination. The filing also notes that information about the interests of Berto’s directors and officers in any proposed transaction can be found in Berto’s existing SEC reports and will be updated in any future proxy statement/prospectus.

Because the letter of intent with OnMed is explicitly described as non-binding and subject to multiple conditions, the available information does not confirm completion of any business combination. Investors reviewing the TACO stock and related securities therefore rely on Berto’s SEC filings and any subsequent registration statements or proxy materials for updates on the status of any proposed transaction.